Table I.
Correlation of LIMD2 expression with clinicopathologic characteristics in non-small cell lung cancer.
| Variable | Cases (n=52) | Low expression (n=26) | High expression (n=26) | P-value |
|---|---|---|---|---|
| Age (years) | 0.41416 | |||
| <60 | 15 | 6 | 9 | |
| ≥60 | 37 | 20 | 17 | |
| Sex | 0.499 | |||
| Male | 41 | 22 | 19 | |
| Female | 11 | 4 | 7 | |
| Smoking | 0.258 | |||
| Yes | 31 | 18 | 13 | |
| No | 21 | 8 | 13 | |
| TNM stage | 0.011a | |||
| I–II | 24 | 17 | 7 | |
| III–IV | 28 | 9 | 19 | |
| Differentiation | 0.093 | |||
| Well and moderate | 23 | 15 | 8 | |
| Poor | 29 | 11 | 18 | |
| Lymph node metastasis | 0.001a | |||
| Yes | 27 | 7 | 20 | |
| No | 25 | 19 | 6 |
a
P<0.05. LIMD2, LIM domain containing 2.